ScholarLens Back to search
2008•Annals of the Rheumatic DiseasesRequires access

Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis

Timothy R. D. J. Radstake, Morten Svenson, A M M Eijsbouts, F.H.J. van den Hoogen, Christian Enevold, Piet L. C. M. van Riel, Klaus Bendtzen

Open publisher page 378 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 378 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Adalimumab, Infliximab, Medicine, Rheumatoid arthritis, Internal medicine, Rheumatology, Arthritis, Concomitant

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis — Research Paper | ScholarLens